{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:34:29Z","timestamp":1790786069467,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["Bristol Cardiovascular Biomedical Research Unit"],"award-info":[{"award-number":["Bristol Cardiovascular Biomedical Research Unit"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["Chair"],"award-info":[{"award-number":["Chair"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University Hospitals Bristol NHSFT"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13054-017-1659-4","type":"journal-article","created":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T11:56:29Z","timestamp":1490702189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":123,"title":["Corticosteroids in septic shock: a systematic review and network meta-analysis"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3635-6212","authenticated-orcid":false,"given":"Ben","family":"Gibbison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"L\u00f3pez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian P. T.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni D.","family":"Angelini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stafford L.","family":"Lightman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djillali","family":"Annane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,28]]},"reference":[{"key":"1659_CR1","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1097\/CCM.0b013e31817603ba","volume":"36","author":"PE Marik","year":"2008","unstructured":"Marik PE, Pastores SM, Annane D, Meduri GU, Sprung CL, Arlt W, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med. 2008;36:1937\u201349.","journal-title":"Crit Care Med."},{"key":"1659_CR2","first-page":"CD002243","volume":"12","author":"D Annane","year":"2015","unstructured":"Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y. Corticosteroids for treating sepsis. Cochrane Database Syst Rev. 2015;12:CD002243.","journal-title":"Cochrane Database Syst Rev."},{"key":"1659_CR3","doi-asserted-by":"crossref","first-page":"R134","DOI":"10.1186\/cc9182","volume":"14","author":"JL Moran","year":"2010","unstructured":"Moran JL, Graham PL, Rockliff S, Bersten AD. Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspective. Crit Care. 2010;14:R134.","journal-title":"Crit Care."},{"key":"1659_CR4","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1007\/s00134-015-3899-6","volume":"41","author":"M Volbeda","year":"2015","unstructured":"Volbeda M, Wetterslev J, Gluud C, Zijlstra JG, van der Horst ICC, Keus F. Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis. Intensive Care Med. 2015;41:1220\u201334.","journal-title":"Intensive Care Med."},{"key":"1659_CR5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0954-6111(98)90280-3","volume":"92","author":"P Demoly","year":"1998","unstructured":"Demoly P, Chung KF. Pharmacology of corticosteroids. Respir Med. 1998;92:385\u201394.","journal-title":"Respir Med."},{"key":"1659_CR6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/03091900802185970","volume":"33","author":"DE Henley","year":"2009","unstructured":"Henley DE, Leendertz JA, Russell GM, Wood SA, Taheri S, Woltersdorf WW, et al. Development of an automated blood sampling system for use in humans. J Med Eng Technol. 2009;33:199\u2013208.","journal-title":"J Med Eng Technol."},{"key":"1659_CR7","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/CCM.0000000000000773","volume":"43","author":"B Gibbison","year":"2015","unstructured":"Gibbison B, Spiga F, Walker JJ, Russell GM, Stevenson K, Kershaw Y, et al. Dynamic pituitary-adrenal interactions in response to cardiac surgery. Crit Care Med. 2015;43:791\u2013800.","journal-title":"Crit Care Med."},{"key":"1659_CR8","doi-asserted-by":"crossref","first-page":"E883","DOI":"10.1152\/ajpendo.00009.2014","volume":"306","author":"E Boonen","year":"2014","unstructured":"Boonen E, Meersseman P, Vervenne H, Meyfroidt G, Gu\u00efza F, Wouters PJ, et al. Reduced nocturnal ACTH-driven cortisol secretion during critical illness. Am J Physiol Endocrinol Metab. 2014;306:E883\u201392.","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"1659_CR9","unstructured":"Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from http:\/\/handbook.cochrane.org ."},{"key":"1659_CR10","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.331.7521.897","volume":"331","author":"DM Caldwell","year":"2005","unstructured":"Caldwell DM. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ. 2005;331:897\u2013900.","journal-title":"BMJ."},{"key":"1659_CR11","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1177\/1536867X1501500403","volume":"15","author":"IR White","year":"2015","unstructured":"White IR. Network meta-analysis. Stata J. 2015;15:951\u201385.","journal-title":"Stata J."},{"key":"1659_CR12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1164\/rccm.200406-808OC","volume":"171","author":"M Confalonieri","year":"2005","unstructured":"Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P, Puccio G, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med. 2005;171:242\u20138.","journal-title":"Am J Respir Crit Care Med."},{"key":"1659_CR13","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(11)60607-7","volume":"377","author":"SCA Meijvis","year":"2011","unstructured":"Meijvis SCA, Hardeman H, Remmelts HHF, Heijligenberg R, Rijkers GT, van Velzen-Blad H, et al. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial. Lancet. 2011;377:2023\u201330.","journal-title":"Lancet."},{"key":"1659_CR14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejcdt.2013.02.013","volume":"62","author":"NA Rezk","year":"2013","unstructured":"Rezk NA, Ibrahim AM. Effects of methyl prednisolone in early ARDS. Egypt J Chest Dis Tuberc. 2013;62:167\u201372.","journal-title":"Egypt J Chest Dis Tuberc."},{"key":"1659_CR15","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1164\/rccm.200905-0808OC","volume":"181","author":"D Snijders","year":"2010","unstructured":"Snijders D, Daniels JMA, de Graaff CS, van der Werf TS, Boersma WG. Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial. Am J Respir Crit Care Med. 2010;181:975\u201382.","journal-title":"Am J Respir Crit Care Med."},{"key":"1659_CR16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.2015.88","volume":"313","author":"A Torres","year":"2015","unstructured":"Torres A, Sibila O, Ferrer M, Polverino E, Menendez R, Mensa J, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA. 2015;313:677\u201386.","journal-title":"JAMA."},{"key":"1659_CR17","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00006454-199607000-00004","volume":"15","author":"T Slusher","year":"1996","unstructured":"Slusher T, Gbadero D, Howard C, Lewison L, Giroir B, Toro L, et al. Randomized, placebo-controlled, double blinded trial of dexamethasone in African children with sepsis. Pediatr Infect Dis J. 1996;15:579\u201383.","journal-title":"Pediatr Infect Dis J."},{"key":"1659_CR18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/PCC.0b013e3181936ab3","volume":"10","author":"HT Valoor","year":"2009","unstructured":"Valoor HT, Singhi S, Jayashree M. Low-dose hydrocortisone in pediatric septic shock: an exploratory study in a Third World setting. Pediatr Crit Care Med. 2009;10:121\u20135.","journal-title":"Pediatr Crit Care Med."},{"key":"1659_CR19","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jama.1963.63700060029012","volume":"183","author":"Cooperative Study Group","year":"1963","unstructured":"Cooperative Study Group. The effectiveness of hydrocortisone in the management of severe infections. JAMA. 1963;183:462\u20135.","journal-title":"JAMA"},{"issue":"12 Suppl","key":"1659_CR20","doi-asserted-by":"crossref","first-page":"A101","DOI":"10.1097\/00003246-200612002-00350","volume":"34","author":"JW Huh","year":"2006","unstructured":"Huh JW, Lim CM, Koh Y, Hong SB. Effect of low doses of hydrocortisone in patient with septic shock and relative adrenal insufficiency: 3\u00a0days versus 7\u00a0days treatment [abstract 369]. Crit Care Med. 2006;34(12 Suppl):A101.","journal-title":"Crit Care Med"},{"key":"1659_CR21","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1164\/rccm.200205-446OC","volume":"167","author":"D Keh","year":"2003","unstructured":"Keh D, Boehnke T, Weber-Cartens S, Schulz C, Ahlers O, Bercker S, et al. Immunologic and hemodynamic effects of \u201clow-dose\u201d hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med. 2003;167:512\u201320.","journal-title":"Am J Respir Crit Care Med."},{"key":"1659_CR22","unstructured":"Tandan SM, Guleria R, Gupta N. Low dose steroids and adrenocortical insufficiency in septic shock: a double-blind randomised controlled trial from India [abstract]. In: Proceedings of the American Thoracic Society Meeting, New York, NY, USA; 2005. p A24."},{"key":"1659_CR23","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1164\/ajrccm\/138.1.62","volume":"138","author":"JM Luce","year":"1988","unstructured":"Luce JM, Montgomery AB, Marks JD, Turner J, Metz CA, Murray JF. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis. 1988;138:62\u20138.","journal-title":"Am Rev Respir Dis."},{"key":"1659_CR24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJM198709103171102","volume":"317","author":"The Veterans Administration Systemic Sepsis Cooperative Study Group","year":"1987","unstructured":"The Veterans Administration Systemic Sepsis Cooperative Study Group. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med. 1987;317:659\u201365.","journal-title":"N Engl J Med"},{"key":"1659_CR25","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJM198709103171101","volume":"317","author":"RC Bone","year":"1987","unstructured":"Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med. 1987;317:653\u20138.","journal-title":"N Engl J Med."},{"key":"1659_CR26","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJM197106032842206","volume":"284","author":"J Klastersky","year":"1971","unstructured":"Klastersky J, Cappel R, Debusscher L. Effectiveness of betamethasone in management of severe infections: a double-blind study. N Engl J Med. 1971;284:1248\u201350.","journal-title":"N Engl J Med."},{"key":"1659_CR27","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/archsurg.1984.01390170037008","volume":"119","author":"CE Lucas","year":"1984","unstructured":"Lucas CE, Ledgerwood AM. The cardiopulmonary response to massive doses of steroids in patients with septic shock. Arch Surg. 1984;119:537\u201341.","journal-title":"Arch Surg."},{"key":"1659_CR28","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1007\/s00134-011-2342-x","volume":"37","author":"N Molenaar","year":"2011","unstructured":"Molenaar N, Johan Groeneveld AB, Dijstelbloem HM, de Jong MF, Girbes AR, Heijboer AC, et al. Assessing adrenal insufficiency of corticosteroid secretion using free versus total cortisol levels in critical illness. Intensive Care Med. 2011;37:1986\u201393.","journal-title":"Intensive Care Med."},{"key":"1659_CR29","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1007\/s001340101073","volume":"27","author":"A Beishuizen","year":"2001","unstructured":"Beishuizen A, Thijs LG, Vermes I. Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma. Intensive Care Med. 2001;27:1584\u201391.","journal-title":"Intensive Care Med."},{"key":"1659_CR30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/0310057X0503300208","volume":"33","author":"B Venkatesh","year":"2005","unstructured":"Venkatesh B, Mortimer RH, Couchman B, Hall J. Evaluation of random plasma cortisol and the low dose corticotropin test as indicators of adrenal secretory capacity in critically ill patients: a prospective study. Anaesth Intensive Care. 2005;33:201\u20139.","journal-title":"Anaesth Intensive Care."},{"key":"1659_CR31","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1001\/jama.283.8.1038","volume":"283","author":"D Annane","year":"2000","unstructured":"Annane D, Sebille V, Troche G, Raphael JC, Gajdos P, Bellissant E. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA. 2000;283:1038\u201345.","journal-title":"JAMA."},{"key":"1659_CR32","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jama.2010.2","volume":"303","author":"COIITSS Study Investigators","year":"2010","unstructured":"COIITSS Study Investigators. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA. 2010;303:341\u20138.","journal-title":"JAMA"},{"key":"1659_CR33","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/CCM.0000000000000212","volume":"42","author":"AC Gordon","year":"2014","unstructured":"Gordon AC, Mason AJ, Perkins GD, Stotz M, Terblanche M, Ashby D, et al. The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial. Crit Care Med. 2014;42:1325\u201333.","journal-title":"Crit Care Med."},{"key":"1659_CR34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4236\/pp.2011.22009","volume":"2","author":"NA Sabry","year":"2011","unstructured":"Sabry NA, Omar EED. Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings. Pharmacol Pharm. 2011;2:73\u201381.","journal-title":"Pharmacol Pharm."},{"key":"1659_CR35","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","volume":"41","author":"RP Dellinger","year":"2013","unstructured":"Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012. Crit Care Med. 2013;41:580\u2013637.","journal-title":"Crit Care Med."},{"key":"1659_CR36","first-page":"34","volume":"37","author":"FM Kenny","year":"1966","unstructured":"Kenny FM, Preeyasombat C, Migeon CJ. Cortisol production rate. II. Normal infants, children, and adults. Pediatrics. 1966;37:34\u201342.","journal-title":"Pediatrics"},{"key":"1659_CR37","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1210\/jc.2006-0076","volume":"91","author":"R Bergthorsdottir","year":"2006","unstructured":"Bergthorsdottir R, Leonsson-Zachrisson M, Od\u00e9n A, Johannsson G. Premature mortality in patients with Addison\u2019s disease: a population-based study. J Clin Endocrinol Metab. 2006;91:4849\u201353.","journal-title":"J Clin Endocrinol Metab."},{"key":"1659_CR38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/cen.12470","volume":"81","author":"GM Russell","year":"2014","unstructured":"Russell GM, Durant C, Ataya A, Papastathi C, Bhake R, Woltersdorf W, et al. Subcutaneous pulsatile glucocorticoid replacement therapy. Clin Endocrinol (Oxf). 2014;81:289\u201393.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1659_CR39","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1365-2826.2010.02051.x","volume":"22","author":"BL Conway-Campbell","year":"2010","unstructured":"Conway-Campbell BL, Sarabdjitsingh RA, McKenna MA, Pooley JR, Kershaw YM, Meijer OC, et al. Glucocorticoid ultradian rhythmicity directs cyclical gene pulsing of the clock gene period 1 in rat hippocampus. J Neuroendocrinol. 2010;22:1093\u2013100.","journal-title":"J Neuroendocrinol."},{"key":"1659_CR40","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.mce.2015.02.005","volume":"408","author":"F Spiga","year":"2015","unstructured":"Spiga F, Lightman SL. Dynamics of adrenal glucocorticoid steroidogenesis in health and disease. Mol Cell Endocrinol. 2015;408:227\u201334.","journal-title":"Mol Cell Endocrinol."},{"key":"1659_CR41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pharmthera.2016.06.020","volume":"166","author":"D Henley","year":"2016","unstructured":"Henley D, Lightman S, Carrell R. Cortisol and CBG\u2014getting cortisol to the right place at the right time. Pharmacol Ther. 2016;166:128\u201335.","journal-title":"Pharmacol Ther."},{"key":"1659_CR42","doi-asserted-by":"publisher","unstructured":"Conway-Campbell B, Birnie M, Flynn B, Kershaw Y, Lightman S. Glucocorticoid pattern-dependent gene regulation in the rat hippocampus [abstract OC3.5]. In: Endocrine Abstracts. Vol. 38. Bristol, UK: BioScientifica; 2015. doi: 10.1530\/endoabs.38.OC3.5 .","DOI":"10.1530\/endoabs.38.OC3.5"},{"key":"1659_CR43","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jrsm.1037","volume":"3","author":"G Salanti","year":"2012","unstructured":"Salanti G. Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool. Res Synth Methods. 2012;3:80\u201397.","journal-title":"Res Synth Methods."},{"key":"1659_CR44","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(10)60446-1","volume":"376","author":"NK Adhikari","year":"2000","unstructured":"Adhikari NK, Fowler RA, Bhagwanjee S, Rubenfeld GD. Critical care and the global burden of critical illness in adults. Lancet. 2000;376:1339\u201346.","journal-title":"Lancet."},{"key":"1659_CR45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","volume":"358","author":"CL Sprung","year":"2008","unstructured":"Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008;358:111\u201324.","journal-title":"N Engl J Med."},{"key":"1659_CR46","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM198411013111801","volume":"311","author":"CL Sprung","year":"1984","unstructured":"Sprung CL, Caralis PV, Marcial EH, Pierce M, Gelbard MA, Long WM, et al. The effects of high-dose corticosteroids in patients with septic shock: a prospective, controlled study. N Engl J Med. 1984;311:1137\u201343.","journal-title":"N Engl J Med."},{"key":"1659_CR47","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","volume":"288","author":"D Annane","year":"2002","unstructured":"Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288:862\u201371.","journal-title":"JAMA."},{"key":"1659_CR48","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1503\/cmaj.090707","volume":"182","author":"YM Arabi","year":"2010","unstructured":"Arabi YM, Aljumah A, Dabbagh O, Tamim HM, Rishu AH, Al-Abdulkareem A, et al. Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial. CMAJ. 2010;182:1971\u20137.","journal-title":"CMAJ."},{"key":"1659_CR49","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00003246-199804000-00010","volume":"26","author":"PE Bollaert","year":"1998","unstructured":"Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med. 1998;26:645\u201350.","journal-title":"Crit Care Med."},{"key":"1659_CR50","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/00003246-199904000-00025","volume":"27","author":"J Briegel","year":"1999","unstructured":"Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med. 1999;27:723\u201332.","journal-title":"Crit Care Med."},{"issue":"Suppl 1","key":"1659_CR51","doi-asserted-by":"crossref","first-page":"33A","DOI":"10.1097\/00003246-199901001-00022","volume":"27","author":"K Chawla","year":"1999","unstructured":"Chawla K, Kupfer Y, Goldman I, Tessler S. Hydrocortisone reverses refractory septic shock [abstract]. Crit Care Med. 1999;27 Suppl 1:33A.","journal-title":"Crit Care Med"},{"key":"1659_CR52","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1590\/S1516-31802007000400009","volume":"125","author":"DD Cicarelli","year":"2007","unstructured":"Cicarelli DD, Vieira JE, Bensenor FE. Early dexamethasone treatment for septic shock patients: a prospective randomized clinical trial. Sao Paulo Med J. 2007;125:237\u201341.","journal-title":"Sao Paulo Med J."},{"key":"1659_CR53","first-page":"529","volume":"21","author":"B Hu","year":"2009","unstructured":"Hu B, Li JG, Liang H, Zhou Q, Yu Z, Li L, et al. The effect of low-dose hydrocortisone on requirement of norepinephrine and lactate clearance in patients with refractory septic shock [in Chinese]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009;21:529\u201331.","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi Xue."},{"key":"1659_CR54","first-page":"599","volume":"51","author":"L Liu","year":"2012","unstructured":"Liu L, Li J, Huang YZ, Liu SQ, Yang CS, Guo FM, et al. The effect of stress dose glucocorticoid on patients with acute respiratory distress syndrome combined with critical illness-related corticosteroid insufficiency [in Chinese]. Zhonghua Nei Ke Za Zhi. 2012;51:599\u2013603.","journal-title":"Zhonghua Nei Ke Za Zhi."},{"key":"1659_CR55","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1378\/chest.06-2100","volume":"131","author":"GU Meduri","year":"2007","unstructured":"Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest. 2007;131:954\u201363.","journal-title":"Chest."},{"key":"1659_CR56","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1097\/01.CCM.0000186370.78639.23","volume":"33","author":"M Oppert","year":"2005","unstructured":"Oppert M, Schindler R, Husung C, Offermann K, Gr\u00e4f KJ, Boenisch O, et al. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med. 2005;33:2457\u201364.","journal-title":"Crit Care Med."},{"key":"1659_CR57","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1097\/01.CCM.0000233872.04706.BB","volume":"34","author":"S Rinaldi","year":"2006","unstructured":"Rinaldi S, Adembri C, Grechi S, De Gaudio AR. Low-dose hydrocortisone during severe sepsis: effects on microalbuminuria. Crit Care Med. 2006;34:2334\u20139.","journal-title":"Crit Care Med."},{"key":"1659_CR58","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00000658-197609000-00011","volume":"184","author":"W Schumer","year":"1976","unstructured":"Schumer W. Steroids in the treatment of clinical septic shock. Ann Surg. 1976;184:333\u201341.","journal-title":"Ann Surg."},{"key":"1659_CR59","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/cc1498","volume":"6","author":"O Yildiz","year":"2002","unstructured":"Yildiz O, Do\u011fanay M, Aygen B, G\u00fcven M, Kele\u015ftimur F, Tutu\u015f A. Physiological-dose steroid therapy in sepsis [ISRCTN36253388]. Crit Care. 2002;6:251\u20139.","journal-title":"Crit Care."},{"key":"1659_CR60","first-page":"1410","volume":"16","author":"O Yildiz","year":"2011","unstructured":"Yildiz O, Tanriverdi F, Simsek S, Aygen B, Kele\u015ftimur F. The effects of moderate-dose steroid therapy in sepsis: a placebo-controlled, randomized study. J Res Med Sci. 2011;16:1410\u201321.","journal-title":"J Res Med Sci."}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-017-1659-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T04:47:42Z","timestamp":1568954862000},"score":1,"resource":{"primary":{"URL":"http:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-017-1659-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,28]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1659"],"URL":"https:\/\/doi.org\/10.1186\/s13054-017-1659-4","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,28]]},"article-number":"78"}}